Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding
CONCLUSION: In the emergency setting, faecal calprotectin could be a helpful marker to select patients with abdominal pain who need second-level radiological examinations or endoscopic procedures, guiding the emergency physician in the evaluation of such a complex and wideranging symptom.PMID:37921137 | DOI:10.2174/0115748871259008231006071656 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: Angela Saviano Carmine Petruzziello Christian Zanza Marcello Candelli Maurizio Gabrielli Alessio Migneco Francesco Franceschi Veronica Ojetti Source Type: research
Regulatory Procedures and Integrated Requirements for Early Phase Development of a Pharmaceutical Drug Product
Rev Recent Clin Trials. 2023 Oct 25. doi: 10.2174/0115748871251739231018104151. Online ahead of print.NO ABSTRACTPMID:37921138 | DOI:10.2174/0115748871251739231018104151 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: None Gaurav Niraj Sandeep Patil Animesh Ranjan Dilpreet Singh Source Type: research
Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding
CONCLUSION: In the emergency setting, faecal calprotectin could be a helpful marker to select patients with abdominal pain who need second-level radiological examinations or endoscopic procedures, guiding the emergency physician in the evaluation of such a complex and wideranging symptom.PMID:37921137 | DOI:10.2174/0115748871259008231006071656 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: Angela Saviano Carmine Petruzziello Christian Zanza Marcello Candelli Maurizio Gabrielli Alessio Migneco Francesco Franceschi Veronica Ojetti Source Type: research
Regulatory Procedures and Integrated Requirements for Early Phase Development of a Pharmaceutical Drug Product
Rev Recent Clin Trials. 2023 Oct 25. doi: 10.2174/0115748871251739231018104151. Online ahead of print.NO ABSTRACTPMID:37921138 | DOI:10.2174/0115748871251739231018104151 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: None Gaurav Niraj Sandeep Patil Animesh Ranjan Dilpreet Singh Source Type: research
Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding
CONCLUSION: In the emergency setting, faecal calprotectin could be a helpful marker to select patients with abdominal pain who need second-level radiological examinations or endoscopic procedures, guiding the emergency physician in the evaluation of such a complex and wideranging symptom.PMID:37921137 | DOI:10.2174/0115748871259008231006071656 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: Angela Saviano Carmine Petruzziello Christian Zanza Marcello Candelli Maurizio Gabrielli Alessio Migneco Francesco Franceschi Veronica Ojetti Source Type: research
Regulatory Procedures and Integrated Requirements for Early Phase Development of a Pharmaceutical Drug Product
Rev Recent Clin Trials. 2023 Oct 25. doi: 10.2174/0115748871251739231018104151. Online ahead of print.NO ABSTRACTPMID:37921138 | DOI:10.2174/0115748871251739231018104151 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: None Gaurav Niraj Sandeep Patil Animesh Ranjan Dilpreet Singh Source Type: research
Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding
CONCLUSION: In the emergency setting, faecal calprotectin could be a helpful marker to select patients with abdominal pain who need second-level radiological examinations or endoscopic procedures, guiding the emergency physician in the evaluation of such a complex and wideranging symptom.PMID:37921137 | DOI:10.2174/0115748871259008231006071656 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: Angela Saviano Carmine Petruzziello Christian Zanza Marcello Candelli Maurizio Gabrielli Alessio Migneco Francesco Franceschi Veronica Ojetti Source Type: research
Regulatory Procedures and Integrated Requirements for Early Phase Development of a Pharmaceutical Drug Product
Rev Recent Clin Trials. 2023 Oct 25. doi: 10.2174/0115748871251739231018104151. Online ahead of print.NO ABSTRACTPMID:37921138 | DOI:10.2174/0115748871251739231018104151 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 3, 2023 Category: Cancer & Oncology Authors: None Gaurav Niraj Sandeep Patil Animesh Ranjan Dilpreet Singh Source Type: research
Predictors of Treatment Outcome and Clinical Profile among GuillainBarre Syndrome Patients in South India
CONCLUSION: Appropriate diagnosis of GBS using both clinical and laboratory evidence and providing appropriate treatment along with more supervision among GBS patients with a history of antecedent illnesses will help improve their prognosis at the time of discharge.PMID:37907491 | DOI:10.2174/0115748871254419231019053136 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 1, 2023 Category: Cancer & Oncology Authors: Nitin Joseph Soumya Shrigiri Source Type: research
Predictors of Treatment Outcome and Clinical Profile among GuillainBarre Syndrome Patients in South India
CONCLUSION: Appropriate diagnosis of GBS using both clinical and laboratory evidence and providing appropriate treatment along with more supervision among GBS patients with a history of antecedent illnesses will help improve their prognosis at the time of discharge.PMID:37907491 | DOI:10.2174/0115748871254419231019053136 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 1, 2023 Category: Cancer & Oncology Authors: Nitin Joseph Soumya Shrigiri Source Type: research
Predictors of Treatment Outcome and Clinical Profile among GuillainBarre Syndrome Patients in South India
CONCLUSION: Appropriate diagnosis of GBS using both clinical and laboratory evidence and providing appropriate treatment along with more supervision among GBS patients with a history of antecedent illnesses will help improve their prognosis at the time of discharge.PMID:37907491 | DOI:10.2174/0115748871254419231019053136 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - November 1, 2023 Category: Cancer & Oncology Authors: Nitin Joseph Soumya Shrigiri Source Type: research
Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study
CONCLUSION: Pregabalin increases the quality of life in patients with subacute and chronic cough resistant to standard treatment and increases the rate of recovery in these patients.PMID:37888808 | DOI:10.2174/0115748871262516230919070559 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - October 27, 2023 Category: Cancer & Oncology Authors: Seyed Hasan Adeli Abolfazl Mohammad Beigi Sajjad Ahmadpour Mohammad Amin Habibi Mohammad Reza Pashaei Ehsan Sharifipour Mansoureh Shakeri Akram Asghari Source Type: research
Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study
CONCLUSION: Pregabalin increases the quality of life in patients with subacute and chronic cough resistant to standard treatment and increases the rate of recovery in these patients.PMID:37888808 | DOI:10.2174/0115748871262516230919070559 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - October 27, 2023 Category: Cancer & Oncology Authors: Seyed Hasan Adeli Abolfazl Mohammad Beigi Sajjad Ahmadpour Mohammad Amin Habibi Mohammad Reza Pashaei Ehsan Sharifipour Mansoureh Shakeri Akram Asghari Source Type: research
Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study
CONCLUSION: Pregabalin increases the quality of life in patients with subacute and chronic cough resistant to standard treatment and increases the rate of recovery in these patients.PMID:37888808 | DOI:10.2174/0115748871262516230919070559 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - October 27, 2023 Category: Cancer & Oncology Authors: Seyed Hasan Adeli Abolfazl Mohammad Beigi Sajjad Ahmadpour Mohammad Amin Habibi Mohammad Reza Pashaei Ehsan Sharifipour Mansoureh Shakeri Akram Asghari Source Type: research
Identification of a Novel TSC2 c.170G & gt;A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations
CONCLUSION: As novel pathogenic variants of TSC genes are constantly being explored, the identification of TSC variants of unknown significance in combination with absent clinical diagnostic criteria cannot exclude a TSC diagnosis. We support the implementation of clinical judgment in assisting the diagnosis of TSC, as well as the enrollment of patients in clinical trials due to the rarity of the disease.PMID:37877150 | DOI:10.2174/0115748871258042230921052344 (Source: Reviews on Recent Clinical Trials)
Source: Reviews on Recent Clinical Trials - October 25, 2023 Category: Cancer & Oncology Authors: Georgios Papageorgiou Nikolaos Skouteris Christos Valavanis Gabriela-Monica Stanc Efthymia Souka Nikolaos Charalampakis Source Type: research
